WallStreetZenWallStreetZen

NASDAQ: LEGN
Legend Biotech Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LEGN past revenue growth

How has LEGN's revenue growth performed historically?
Company
143.7%
Industry
151.46%
Market
17.61%
LEGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LEGN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LEGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LEGN earnings and revenue history

Current Revenue
$285.1M
Current Earnings
-$518.3M
Current Profit Margin
-181.8%

LEGN Return on Equity

Current Company
-44.6%
Current Industry
-63.5%
Current Market
188%
LEGN's Return on Equity (-44.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LEGN announces earnings.

LEGN Return on Assets

Current Company
-30.4%
Current Industry
2.9%
LEGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LEGN Return on Capital Employed

Current Company
-30.53%
Current Industry
19.5%
LEGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LEGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LEGN$285.14M-$477.87M-$518.25M+42.15%N/A
ROIV$123.24M$4.58B$4.47B+41.90%N/A
ASND$286.79M-$442.12M-$517.68M+89.39%N/A
CERE$0.00-$416.15M-$432.84MN/AN/A
TECH$1.14B$372.91M$224.16M+10.93%+17.11%
View Top Biotech Stocks

LEGN earnings dates

Next earnings date
May 13, 2024

Legend Biotech Earnings & Revenue FAQ

What were LEGN's earnings last quarter?

On Invalid Date, Legend Biotech (NASDAQ: LEGN) reported Q4 2023 earnings per share (EPS) of -$0.80, up 2.44% year over year. Total Legend Biotech earnings for the quarter were -$144.82 million. In the same quarter last year, Legend Biotech's earnings per share (EPS) was -$0.82.

If you're new to stock investing, here's how to buy Legend Biotech stock.

What was LEGN's earnings growth in the past year?

As of Q2 2024, Legend Biotech's earnings has grown year over year. Legend Biotech's earnings in the past year totalled -$518.25 million.

What is LEGN's earnings date?

Legend Biotech's earnings date is Invalid Date. Add LEGN to your watchlist to be reminded of LEGN's next earnings announcement.

What was LEGN's revenue last quarter?

On Invalid Date, Legend Biotech (NASDAQ: LEGN) reported Q4 2023 revenue of $79.46 million up 187.57% year over year. In the same quarter last year, Legend Biotech's revenue was $27.63 million.

What was LEGN's revenue growth in the past year?

As of Q2 2024, Legend Biotech's revenue has grown 143.7% year over year. This is 7.76 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Legend Biotech's revenue in the past year totalled $285.14 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.